跳至主要内容
临床试验/NCT06792708
NCT06792708已完成不适用

A Prospective, Multicenter, Observational Study of LUMRYZ Used in Clinical Practice for the Treatment of Narcolepsy

Avadel24 个研究点 分布在 1 个国家目标入组 71 人开始时间: 2024年7月18日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Avadel
入组人数
71
试验地点
24
主要终点
Epworth Sleepiness Scale

研究概览

简要总结

This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults with narcolepsy
  • Oxybate naive or prior treatment with twice-nightly oxybate
  • Access to smart phone, tablet or laptop with reliable internet connection
  • Able to read/understand English
  • Written informed consent and ability to comply with schedule

排除标准

  • Already using LUMRYZ
  • Clinical or mental health condition excluded by LUMRYZ label
  • Any other condition/situation that would adversely impact participation

研究组 & 干预措施

Patients Starting LUMRYZ

The cohort is comprised of patients prescribed LUMRYZ in clinical practice. All dosing decisions are made by the clinician.

干预措施: LUMRYZ (Drug)

结局指标

主要结局

Epworth Sleepiness Scale

时间窗: Baseline to Month 4

Change from the first visit (baseline), prior to start of LUMRYZ, to Month 4; measure of sleepiness with total possible score of 0-24 (higher score equivalent to higher sleepiness)

次要结局

未报告次要终点

研究者

发起方
Avadel
申办方类型
Industry
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验